National Graphite Corp. is an exploration company, which engages in the exploration of gold, silver, and related minerals. The company is headquartered in Dusseldorf, Nordrhein-Westfalen. The company went IPO on 2009-06-30. The firm is pursuing the commercial development of a drug candidate, elafin, for the treatment of postoperative inflammatory complications. Elafin is a human identic protein. The firm operates in Germany, in collaboration with clinical-stage companies that develop new biological entities or new therapeutically platforms in the treatment for various diseases, rare diseases and diseases with unmet needs. Biotech Development Corp. is the Company's subsidiary. As of February 28, 2015, the Company had not generated any revenues.
NGRC stock price ended at $0.04 on 화요일, after rising 0.00%
On the latest trading day Jan 13, 2026, the stock price of NGRC rose by 0.00%, climbing from $0.03 to $0.04. Throughout the session, the stock experienced a volatility of 33.33%, with prices fluctuating between a daily low of $0.03 and a high of $0.04. Alongside this price increase, trading volume also rose by 11.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 29.8K shares were traded, amounting to a market value of approximately $6.1M.
NGRC 기술적 시그널
기술적 시그널 요약
구매 신호 3
중립 신호 0
매도 신호 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
NGRC은 현재 3개의 매수 신호와 4개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
NGRC에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 NGRC 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.